155
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Drug Monitoring of PEG-Asparaginase Treatment in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

, , , , , & show all
Pages 1911-1920 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cecilia H Fu & Kathleen M Sakamoto. (2007) PEG-asparaginase. Expert Opinion on Pharmacotherapy 8:12, pages 1977-1984.
Read now

Articles from other publishers (15)

Line Stensig Lynggaard, Cecilie U Rank, Bodil Als-Nielsen, Sofie G Hoejfeldt, Mats Heyman, Kjeld Schmiegelow & Birgitte K Albertsen. (2023) PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Rajashekar Sindhu & Haravey K. Manonmani. (2022) L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review. Anti-Cancer Agents in Medicinal Chemistry 22:13, pages 2393-2410.
Crossref
Line Stensig Lynggaard, Cecilie U Rank, Bodil Als-Nielsen, Sofie G Hoejfeldt, Mats Heyman, Kjeld Schmiegelow & Birgitte K Albertsen. (2021) PEG-asparaginase treatment for acute lymphoblastic leukaemia in children: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Joël Bourquin, Ana Milosevic, Daniel Hauser, Roman Lehner, Fabian Blank, Alke Petri‐Fink & Barbara Rothen‐Rutishauser. (2018) Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials. Advanced Materials 30:19.
Crossref
N. N. Sokolov, M. A. Eldarov, M. V. Pokrovskaya, S. S. Aleksandrova, O. Yu. Abakumova, O. V. Podobed, N. S. Melik-Nubarov, E. V. Kudryashova, D. V. Grishin & A. I. Archakov. (2015) Bacterial recombinant L-asparaginases: Properties, structure, and anti-proliferative activity. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 9:4, pages 325-338.
Crossref
N.N. Sokolov, M.A. Eldarov, M.V. Pokrovskaya, S.S. Aleksandrova, O.Yu. Abakumova, O.V. Podobed, N.S. Melik-Nubarov, E.V. Kudryashova, D.V. Grishin & A.I. Archakov. (2015) Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity. Biomeditsinskaya Khimiya 61:3, pages 312-324.
Crossref
Stephan Borghorst, Georg Hempel, Sabine Poppenborg, Dieter Franke, Thorsten König & Joachim Baumgart. (2014) Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli l-asparaginase preparation (MC0609) in Beagle dog. Cancer Chemotherapy and Pharmacology 74:2, pages 367-378.
Crossref
Rong Shi & Hartmut Derendorf. (2010) Pediatric Dosing and Body Size in Biotherapeutics. Pharmaceutics 2:4, pages 389-418.
Crossref
Georg Hempel, Hans-Joachim Müller, Claudia Lanvers-Kaminsky, Gudrun Würthwein, Antje Hoppe & Joachim Boos. (2010) A population pharmacokinetic model for pegylated-asparaginase in children. British Journal of Haematology 148:1, pages 119-125.
Crossref
Huimin Qian, Yueqing Gu, Min Wang & Samuel Achilefu. (2008) Optimization of the Near-Infrared Fluorescence Labeling for In Vivo Monitoring of a Protein Drug Distribution in Animal Model. Journal of Fluorescence 19:2, pages 277-284.
Crossref
Jonathan K. Armstrong, Georg Hempel, Susanne Koling, Linda S. Chan, Timothy Fisher, Herbert J. Meiselman & George Garratty. (2007) Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients. Cancer 110:1, pages 103-111.
Crossref
Vaskar Saha & Judith Chessells. 2007. Evidence‐based Pediatric Oncology. Evidence‐based Pediatric Oncology 250 278 .
H Gadner, G Masera, M Schrappe, T Eden, Y Benoit, C Harrison, J Nachman & C-H Pui. (2005) The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005. Leukemia 20:1, pages 9-17.
Crossref
João Paulo Vieira Pinheiro & Joachim Boos. (2004) The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined?. British Journal of Haematology 125:2, pages 117-127.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.